Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.

British journal of haematology - 1 May 2013

Dinner Shira, Witteles Wesley, Witteles Ronald, Lam Anthony, Arai Sally, Lafayette Richard, George Tracy I, Schrier Stanley L, Liedtke Michaela

Abstract excerpt

The prevalence and prognostic value of a concomitant diagnosis of symptomatic or asymptomatic multiple myeloma (MM), as defined by the current International Myeloma Working Group (IMWG) criteria, in patients with immunoglobulin light chain amyloidosis (AL), are unknown. We studied 46 consecutive patients with AL who underwent quantification of serum M-protein and clonal bone marrow plasma cells, as well as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Amyloidosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Marrow Examination

Share to Immunoglobulin Light Chains

Share to Multiple Myeloma

Share to Plasma Cells

Share to Syndecan-1

Share to Viscera

Source

Identifiers

PMID: 23432783
DOI: 10.1111/bjh.12269

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.PMID 23432783Read ↗

Cellular diversity and genetic alterations in light chain amyloidosis and amyloidosis with co-occurring multiple myelomaSemantic proximity Read ↗

Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.Semantic proximity Read ↗

Non-secretory multiple myeloma: from biology to clinical managementSemantic proximity Read ↗

Epidemiology of Systemic Light-Chain (AL) AmyloidosisSemantic proximity Read ↗

Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.Semantic proximity Read ↗

Quantitative Imaging and Radiomics in Multiple Myeloma: opportunity or hype?Semantic proximity Read ↗

Biomarkers in AL AmyloidosisSemantic proximity Read ↗

Skeletal health in the precursor stages of multiple myeloma: fracture risk and bone phenotypes in monoclonal gammopathy of undetermined significance and smouldering myeloma.Semantic proximity Read ↗

The role of soluble B cell maturation antigen as a biomarker in multiple myelomaSemantic proximity Read ↗

Divergent Clinical Phenotypes, Organ Involvement, and Survival in AL Amyloidosis and Light Chain Deposition Disease: Insights From a Large Single-Center CohortSemantic proximity Read ↗

Spleen involvement at diagnosis of multiple myeloma: a case report and literature reviewSemantic proximity Read ↗

NONAMYLOIDOTIC MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASESemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.